Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Kalincik

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2019
Real-world studies provide reliable comparisons of disease modifying therapies in MS - YesTomas Kalincik
Neuroepidemiology|May 23, 2015
Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic ReviewTomas Kalincik
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2018
Where there is inflammation, treatment may reduce disability progression - YesTomas Kalincik
Neurology|March 17, 2019
Effectiveness of oral multiple sclerosis therapies in clinical contextTomas Kalincik
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2024
The era of harmonised disability outcomes in multiple sclerosisTomas Kalincik
Brain : a Journal of Neurology|March 8, 2018
Reply: Towards personalized therapy for multiple sclerosis: limitations of observational dataTomas Kalincik
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2017
Stop inflammation and you stop neurodegeneration in MS - NOTomas Kalincik
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2018
Comparisons of therapies in different scenarios help complete the puzzleTomas Kalincik
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2023
How effective is effective enough?Tomas Kalincik, Amy Brodtmann
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 9, 2016
Observational data: Understanding the real MS worldTomas Kalincik, Helmut Butzkueven
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2019
Real-world studies provide reliable comparisons of disease modifying therapies in MS - YesTomas Kalincik
Neuroepidemiology|May 23, 2015
Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic ReviewTomas Kalincik
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2018
Where there is inflammation, treatment may reduce disability progression - YesTomas Kalincik
Neurology|March 17, 2019
Effectiveness of oral multiple sclerosis therapies in clinical contextTomas Kalincik
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2024
The era of harmonised disability outcomes in multiple sclerosisTomas Kalincik
Brain : a Journal of Neurology|March 8, 2018
Reply: Towards personalized therapy for multiple sclerosis: limitations of observational dataTomas Kalincik
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2017
Stop inflammation and you stop neurodegeneration in MS - NOTomas Kalincik
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2018
Comparisons of therapies in different scenarios help complete the puzzleTomas Kalincik
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2023
How effective is effective enough?Tomas Kalincik, Amy Brodtmann
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 9, 2016
Observational data: Understanding the real MS worldTomas Kalincik, Helmut Butzkueven
Pageof 27